These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats. Bishop C, Walker PD. Neuroscience; 2003 Apr 15; 121(3):649-57. PubMed ID: 14568025 [Abstract] [Full Text] [Related]
9. Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system. Kostrzewa RM, Brus R, Perry KW. Pol J Pharmacol; 1999 Apr 15; 51(1):39-47. PubMed ID: 10389143 [Abstract] [Full Text] [Related]
10. Proposed animal model of attention deficit hyperactivity disorder. Kostrzewa RM, Brus R, Kalbfleisch JH, Perry KW, Fuller RW. Brain Res Bull; 1994 Apr 15; 34(2):161-7. PubMed ID: 7913871 [Abstract] [Full Text] [Related]
11. p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's Disease. Kostrzewa JP, Kostrzewa RM. Neurotox Res; 2020 Mar 15; 37(3):543-552. PubMed ID: 31939043 [Abstract] [Full Text] [Related]
12. Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum. Nowak P, Bortel A, Dabrowska J, Biedka I, Slomian G, Roczniak W, Kostrzewa RM, Brus R. Neurotox Res; 2008 Mar 15; 13(3-4):231-40. PubMed ID: 18522902 [Abstract] [Full Text] [Related]
13. Impairment in Pain Perception in Adult Rats Lesioned as Neonates with 5.7-Dihydroxytryptamine. Muchacki R, Szkilnik R, Malinowska-Borowska J, Żelazko A, Lewkowicz Ł, Nowak PG. Adv Clin Exp Med; 2015 Mar 15; 24(3):419-27. PubMed ID: 26467129 [Abstract] [Full Text] [Related]
14. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine. Fletcher PJ, Selhi ZF, Azampanah A, Sills TL. Neuropsychopharmacology; 2001 Apr 15; 24(4):399-409. PubMed ID: 11182535 [Abstract] [Full Text] [Related]
15. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS, Joyce JN. Dev Psychobiol; 1998 May 15; 32(4):313-26. PubMed ID: 9589220 [Abstract] [Full Text] [Related]
16. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors. Karamanakos PN, Pappas P, Marselos M. Behav Brain Res; 2004 Jan 05; 148(1-2):199-208. PubMed ID: 14684260 [Abstract] [Full Text] [Related]
17. Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease. Brus R, Jochem J, Nowak P, Adwent M, Boroń D, Brus H, Kostrzewa RM. Neurotox Res; 2012 Feb 05; 21(2):143-8. PubMed ID: 21822760 [Abstract] [Full Text] [Related]
18. Influence of different histamine receptor agonists and antagonists on apomorphine-induced licking behavior in rat. Farzin D, Attarzadeh M. Eur J Pharmacol; 2000 Sep 15; 404(1-2):169-74. PubMed ID: 10980276 [Abstract] [Full Text] [Related]
19. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Plech A, Brus R, Kalbfleisch JH, Kostrzewa RM. Psychopharmacology (Berl); 1995 Jun 15; 119(4):466-73. PubMed ID: 7480527 [Abstract] [Full Text] [Related]
20. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats. Gong L, Kostrzewa RM, Kalbfleisch JH. Peptides; 1993 Jun 15; 14(6):1159-64. PubMed ID: 7907787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]